Ackrell Capital Cannabis Investment Report – Terpene Benefits Overview (Dec 2017)

Ackrell Capital Cannabis Investment Report – Terpene Benefits Overview (Dec 2017) The passage is a generic industry report describing terpene profiles and alleged medicinal benefits. It contains no references to high‑profile individuals, government agencies, financial transactions, or controversial actions. As such it offers no actionable investigative leads. Key insights: Describes therapeutic claims for various cannabis terpenes (myrcene, pinene, limonene, camphene).; Provides a table of purported medical benefits (antianxiety, anti‑inflammatory, etc.).; Published by Ackrell Capital, a FINRA‑registered investment firm.